Trial Profile
Justification for Atherosclerosis Regression Treatment
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 17 May 2016
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary) ; Pravastatin
- Indications Atherosclerosis; Hypercholesterolaemia
- Focus Therapeutic Use
- 17 May 2016 New trial record